{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:29:51Z","timestamp":1790666991136,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11926-013-0381-8","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T09:12:34Z","timestamp":1383124354000},"source":"Crossref","is-referenced-by-count":10,"title":["Scleroderma-Related Lung Disease: Are Adipokines Involved Pathogenically?"],"prefix":"10.1007","volume":"15","author":[{"given":"Shannon","family":"Haley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Summer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"381_CR1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66:940\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"381_CR2","first-page":"iii40","volume":"48","author":"AU Wells","year":"2009","unstructured":"Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford, England). 2009;48 Suppl 3:iii40\u20134.","journal-title":"Rheumatology (Oxford, England)"},{"key":"381_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000418501","volume":"63","author":"RL Leibel","year":"1990","unstructured":"Leibel RL, Bahary N, Friedman JM. Genetic variation and nutrition in obesity: approaches to the molecular genetics of obesity. World Rev Nutr Diet. 1990;63:90\u2013101.","journal-title":"World Rev Nutr Diet"},{"key":"381_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2009.04.121","volume":"384","author":"N Kiguchi","year":"2009","unstructured":"Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Leptin enhances CC-chemokine ligand expression in cultured murine macrophage. Biochem Biophys Res Commun. 2009;384:311\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"381_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","volume":"393","author":"G Fr\u00fchbeck","year":"2006","unstructured":"Fr\u00fchbeck G. Intracellular signalling pathways activated by leptin. Biochem J. 2006;393:7\u201320.","journal-title":"Biochem J"},{"key":"381_CR6","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.M204598200","volume":"278","author":"GS Kim","year":"2003","unstructured":"Kim GS, Hong JS, Kim SW, Koh J-M, An CS, Choi J-Y, et al. Leptin induces apoptosis via ERK\/cPLA2\/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem. 2003;278:21920\u20139.","journal-title":"J Biol Chem"},{"key":"381_CR7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj20021270","volume":"370","author":"MG Dreyer","year":"2003","unstructured":"Dreyer MG, Juge-Aubry CE, Gabay C, Lang U, Rohner-Jeanrenaud F, Dayer J-M, et al. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42\/44 mitogen-activated protein kinase and a composite nuclear factor kappa B\/PU.1 binding site. Biochem J. 2003;370:591\u20139.","journal-title":"Biochem J"},{"key":"381_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3132\/dvdr.2008.020","volume":"5","author":"A Tomizawa","year":"2008","unstructured":"Tomizawa A, Hattori Y, Kasai K, Nakano Y. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diabetes Vasc Dis Res Off J Int Soc Diabetes Vasc Disease Soc Diabetes Vasc Dis. 2008;5:123\u20137.","journal-title":"Diabetes Vasc Dis Res Off J Int Soc Diabetes Vasc Disease Soc Diabetes Vasc Dis"},{"key":"381_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","volume":"15","author":"Y Pehlivan","year":"2012","unstructured":"\u2022\u2022 Pehlivan Y, Onat AM, Ceylan N, Turkbeyler IH, Buyukhatipoglu H, Comez G, et al. Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis. 2012;15:374\u20139. This study was one of the first to investigate the relationship between circulating adipokines and scleroderma.","journal-title":"Int J Rheum Dis"},{"key":"381_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.MIB.0000200345.38837.46","volume":"12","author":"K Karmiris","year":"2006","unstructured":"Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:100\u20135.","journal-title":"Inflamm Bowel Dis"},{"key":"381_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s100670170053","volume":"20","author":"A Kotulska","year":"2001","unstructured":"Kotulska A, Kucharz EJ, Brzezi\u0144ska-Wcis\u0142o L, Wadas U. A decreased serum leptin level in patients with systemic sclerosis. Clin Rheumatol. 2001;20:300\u20132.","journal-title":"Clin Rheumatol"},{"key":"381_CR12","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.90599.2008","volume":"297","author":"R Summer","year":"2009","unstructured":"Summer R, Fiack CA, Ikeda Y, Sato K, Dwyer D, Ouchi N, et al. Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol. 2009;297:L432\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"381_CR13","doi-asserted-by":"crossref","first-page":"e69297","DOI":"10.1371\/journal.pone.0069297","volume":"8","author":"H Chen","year":"2013","unstructured":"Chen H, Zhang J-P, Huang H, Wang Z-H, Cheng R, Cai W-B. Leptin promotes fetal lung maturity and upregulates SP-A expression in pulmonary alveoli type-II epithelial cells involving TTF-1 activation. PloS One. 2013;8:e69297.","journal-title":"PloS One"},{"key":"381_CR14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pupt.2013.03.016","volume":"26","author":"JHJ Vernooy","year":"2013","unstructured":"Vernooy JHJ, Ubags NDJ, Brusselle GG, Tavernier J, Suratt BT, Joos GF, et al. Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther. 2013;26:464\u201372.","journal-title":"Pulm Pharmacol Ther"},{"key":"381_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2353\/ajpath.2009.081170","volume":"175","author":"WD Hardie","year":"2009","unstructured":"Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol. 2009;175:3\u201316.","journal-title":"Am J Pathol"},{"key":"381_CR16","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.lpm.2010.09.015","volume":"40","author":"PM Hassoun","year":"2011","unstructured":"\u2022 Hassoun PM. Lung involvement in systemic sclerosis. Presse M\u00e9d (Paris, France: 1983). 2011;40:e3\u2013e17. This review is a comprehensive overview of scleroderma-associated ILD and PAH.","journal-title":"Presse M\u00e9d (Paris, France: 1983)"},{"key":"381_CR17","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","volume":"54","author":"NW Morrell","year":"2009","unstructured":"Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S20\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"381_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hfc.2012.04.001","volume":"8","author":"SC Mathai","year":"2012","unstructured":"\u2022 Mathai SC, Hassoun PM. Pulmonary arterial hypertension in connective tissue diseases. Heart Fail Clin. 2012;8:413\u201325. This is a good review of pulmonary arterial hypertension in connective tissue disease.","journal-title":"Heart Fail Clin"},{"key":"381_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10067-006-0302-6","volume":"26","author":"M Benan","year":"2007","unstructured":"Benan M, Hande I, Gul O. The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol. 2007;26:349\u201354.","journal-title":"Clin Rheumatol"},{"key":"381_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1183\/09059180.00001813","volume":"22","author":"S Cappelli","year":"2013","unstructured":"Cappelli S, Guiducci S, Bellando Randone S, Matucci Cerinic M. Immunosuppression for interstitial lung disease in systemic sclerosis. Eur Respir Rev. 2013;22:236\u201343.","journal-title":"Eur Respir Rev"},{"key":"381_CR21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-200111000-00008","volume":"13","author":"JG Coghlan","year":"2001","unstructured":"Coghlan JG, Mukerjee D. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol. 2001;13:495\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"381_CR22","doi-asserted-by":"crossref","unstructured":"Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, et al. Survival and predictors of mortality in systemic sclerosis associated pulmonary arterial hypertension: outcomes from the PHAROS registry. Arthritis Care Res. 2013. doi: 10.1002\/acr.22121 .","DOI":"10.1002\/acr.22121"},{"key":"381_CR23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","volume":"181","author":"J Pavec Le","year":"2010","unstructured":"Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1285\u201393.","journal-title":"Am J Respir Crit Care Med"},{"key":"381_CR24","doi-asserted-by":"crossref","unstructured":"Lef\u00e8vre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013. doi: 10.1002\/art.38029 .","DOI":"10.1002\/art.38029"},{"key":"381_CR25","unstructured":"Rubin R, Strayer DS. Interstitial lung disease; pulmonary hypertension. In: Rubin E, editor. Rubin\u2019s pathology clinicopathologic foundations of medicine, 5th Ed., Lippincott Williams & Wilkins; 2008, p. 524\u201334;536\u2013538."},{"key":"381_CR26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/en.143.3.998","volume":"143","author":"TP Combs","year":"2002","unstructured":"Combs TP, Wagner JA, Berger J, Doebber T, Wang W-J, Zhang BB, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002;143:998\u20131007.","journal-title":"Endocrinology"},{"key":"381_CR27","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1152\/ajpendo.00208.2011","volume":"301","author":"F Addabbo","year":"2011","unstructured":"Addabbo F, Nacci C, De Benedictis L, Leo V, Tarquinio M, Quon MJ, et al. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1\/NF-\u03baB\/COX-2 signaling in human aortic endothelial cells. Am J Physiol Endocrinol Metab. 2011;301:E1143\u201354.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"381_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1165\/rcmb.2008-0415OC","volume":"41","author":"BD Medoff","year":"2009","unstructured":"Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, et al. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol. 2009;41:397\u2013406.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"381_CR29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1165\/rcmb.2010-0316OC","volume":"45","author":"M Weng","year":"2011","unstructured":"\u2022\u2022 Weng M, Raher MJ, Leyton P, Combs TP, Scherer PE, Bloch KD, et al. Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension. Am J Respir Cell Mol Biol. 2011;45:340\u20137. This study was the second to demonstrate the importance of adiponectin in lung vascular remodeling.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"381_CR30","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1210\/en.2007-1561","volume":"149","author":"T Schraw","year":"2008","unstructured":"Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008;149:2270\u201382.","journal-title":"Endocrinology"},{"key":"381_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"381_CR32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1373\/49.4.650","volume":"49","author":"T Pischon","year":"2003","unstructured":"Pischon T. Adiponectin: stability in plasma over 36\u00a0hours and within-person variation over 1 year. Clin Chem. 2003;49:650\u20132.","journal-title":"Clin Chem"},{"key":"381_CR33","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","volume":"285","author":"JM Bruun","year":"2003","unstructured":"Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285:E527\u201333.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"381_CR34","doi-asserted-by":"crossref","unstructured":"Matsuda M, Shimomura I. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Rev Endocr Metab Disord. 2013. doi: 10.1007\/s11154-013-9271-7 .","DOI":"10.1007\/s11154-013-9271-7"},{"key":"381_CR35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10165-012-0660-7","volume":"23","author":"Y Masui","year":"2013","unstructured":"Masui Y, Asano Y, Takahashi T, Shibata S, Akamata K, Aozasa N, et al. Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis. Mod Rheumatol Jpn Rheum Assoc. 2013;23:323\u20139.","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"key":"381_CR36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","volume":"121","author":"G Fantuzzi","year":"2008","unstructured":"Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2008;121:326\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"381_CR37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.2009.178590","volume":"96","author":"F Sam","year":"2010","unstructured":"Sam F, Walsh K. What can adiponectin say about left ventricular function? Heart. 2010;96:331\u20132.","journal-title":"Heart"},{"key":"381_CR38","doi-asserted-by":"crossref","first-page":"e41088","DOI":"10.1371\/journal.pone.0041088","volume":"7","author":"AS Williams","year":"2012","unstructured":"\u2022 Williams AS, Kasahara DI, Verbout NG, Fedulov AV, Zhu M, Si H, et al. Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses in mice. PloS One. 2012;7:e41088. This study illustrates the importance of T-cadherin in facilitating the mobilization of adiponectin into the lung.","journal-title":"PloS One"},{"key":"381_CR39","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1172\/JCI43464","volume":"120","author":"MS Denzel","year":"2010","unstructured":"Denzel MS, Scimia M-C, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010;120:4342\u201352.","journal-title":"J Clin Invest"},{"key":"381_CR40","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4049\/jimmunol.182.1.684","volume":"182","author":"M Miller","year":"2009","unstructured":"Miller M, Cho JY, Pham A, Ramsdell J, Broide DH. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol (Baltimore, Md: 1950). 2009;182:684\u201391.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"381_CR41","doi-asserted-by":"crossref","first-page":"L1035","DOI":"10.1152\/ajplung.00397.2007","volume":"294","author":"R Summer","year":"2008","unstructured":"Summer R, Little FF, Ouchi N, Takemura Y, Aprahamian T, Dwyer D, et al. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1035\u201342.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"381_CR42","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/01.CIR.0000018622.84402.FF","volume":"105","author":"Y Arita","year":"2002","unstructured":"Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893\u20138.","journal-title":"Circulation"},{"key":"381_CR43","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","volume":"277","author":"M Matsuda","year":"2002","unstructured":"Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487\u201391.","journal-title":"J Biol Chem"},{"key":"381_CR44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","volume":"84","author":"GK Owens","year":"2004","unstructured":"Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767\u2013801.","journal-title":"Physiol Rev"},{"key":"381_CR45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/ATVBAHA.110.216804","volume":"31","author":"M Ding","year":"2011","unstructured":"Ding M, Xie Y, Wagner RJ, Jin Y, Carrao AC, Liu LS, et al. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol. 2011;31:1403\u201310.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"381_CR46","first-page":"917","volume":"19","author":"W Wang","year":"2011","unstructured":"Wang W, Zhao C, Wang Y, He X, Shen C, Cao W, et al. Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chin J Hepatol. 2011;19:917\u201322.","journal-title":"Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chin J Hepatol"},{"key":"381_CR47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1468-3083.2011.04077.x","volume":"26","author":"Y Masui","year":"2012","unstructured":"Masui Y, Asano Y, Shibata S, Noda S, Aozasa N, Akamata K, et al. Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. J Eur Acad Dermatol Venereol JEADV. 2012;26:354\u201360.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"381_CR48","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1186\/ar4070","volume":"14","author":"F Fang","year":"2012","unstructured":"\u2022\u2022 Fang F, Liu L, Yang Y, Tamaki Z, Wei J, Marangoni RG, et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther. 2012;14:R229. This study, the first to demonstrate the anti-fibrotic effects of adiponectin in normal and scleroderma fibroblasts, elucidated signaling pathways important for this effect.","journal-title":"Arthritis Res Ther"},{"key":"381_CR49","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/diab.45.11.1511","volume":"45","author":"JW Kolaczynski","year":"1996","unstructured":"Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, et al. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes. 1996;45:1511\u20135.","journal-title":"Diabetes"},{"key":"381_CR50","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1357-2725(98)00094-6","volume":"30","author":"P Prolo","year":"1998","unstructured":"Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol. 1998;30:1285\u201390.","journal-title":"Int J Biochem Cell Biol"},{"key":"381_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-5793(95)00977-H","volume":"373","author":"T Madej","year":"1995","unstructured":"Madej T, Boguski MS, Bryant SH. Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 1995;373:13\u20138.","journal-title":"FEBS Lett"},{"key":"381_CR52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fasebj.12.1.57","volume":"12","author":"S Loffreda","year":"1998","unstructured":"Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12:57\u201365.","journal-title":"FASEB J"},{"key":"381_CR53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1183\/09031936.00159911","volume":"40","author":"A Huertas","year":"2012","unstructured":"\u2022\u2022 Huertas A, Tu L, Gambaryan N, Girerd B, Perros F, Montani D, et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J. 2012;40:895\u2013904. This study was one of the first to show that serum levels of leptin are increased in patients with scleroderma-associated PAH, compared with controls.","journal-title":"Eur Respir J"},{"key":"381_CR54","first-page":"471","volume":"63","author":"G Biesiada","year":"2012","unstructured":"Biesiada G, Czepiel J, Ptak-Belowska A, Targosz A, Krzysiek-Maczka G, Strzalka M, et al. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. J Physiol Pharmacol Off J Pol Physiol Soc. 2012;63:471\u201381.","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"381_CR55","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/beem.2002.0223","volume":"16","author":"DM Muoio","year":"2002","unstructured":"Muoio DM, Lynis Dohm G. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab. 2002;16:653\u201366.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"381_CR56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","volume":"59","author":"C Bj\u00f8rbaek","year":"2004","unstructured":"Bj\u00f8rbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res. 2004;59:305\u201331.","journal-title":"Recent Prog Horm Res"},{"key":"381_CR57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cellbi.2003.12.003","volume":"28","author":"K Hegyi","year":"2004","unstructured":"Hegyi K, F\u00fcl\u00f6p K, Kov\u00e1cs K, T\u00f3th S, Falus A. Leptin-induced signal transduction pathways. Cell Biol Int. 2004;28:159\u201369.","journal-title":"Cell Biol Int"},{"key":"381_CR58","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1164\/rccm.201009-1409OC","volume":"183","author":"M Jain","year":"2011","unstructured":"\u2022\u2022 Jain M, Budinger GRS, Lo A, Urich D, Rivera SE, Ghosh AK, et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-\u03b3. Am J Respir Crit Care Med. 2011;183:1490\u20138. This was the first study to demonstrate that leptin promotes the development of bleomycin-induced lung fibrosis in mice by augmentation of TGF-\u03b2 signaling.","journal-title":"Am J Respir Crit Care Med"},{"key":"381_CR59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2010.03.005","volume":"323","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Jia X, Qin J, Lu C, Zhu H, Li X, et al. Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol Cell Endocrinol. 2010;323:193\u2013200.","journal-title":"Mol Cell Endocrinol"},{"key":"381_CR60","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bjs.5530","volume":"94","author":"MR Hoda","year":"2007","unstructured":"Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, Barrett KE. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg. 2007;94:346\u201354.","journal-title":"Br J Surg"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0381-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0381-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T15:50:13Z","timestamp":1564588213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0381-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,31]]},"article-number":"381"}}